Literature DB >> 11724543

Coxsackievirus and adenovirus receptor (CAR) binds immunoglobulins.

S D Carson1, N M Chapman.   

Abstract

The coxsackievirus and adenovirus receptor protein (CAR) serves as the cell surface receptor for group B coxsackieviruses and most adenoviruses, but the physiological function and ligand for this protein remain to be described. An affinity column was constructed with the recombinant extracellular domain of the CAR (rECAR) to isolate potential ligands by affinity chromatography. Immunoglobulins G and M were consistently isolated from human sera passed through the column, suggesting that the CAR may be an immunoglobulin-binding protein. Further investigation revealed that the affinity-purified immunoglobulins bound to rECAR-coated immunoassay plates, and the peroxidase-labeled rECAR bound the immunoglobulins on ligand-overlay blots. The peroxidase-labeled rECAR was incorporated into immunoprecipitates formed between the affinity-purified immunoglobulins and rabbit antibodies against human immunoglobulins, but not into immunoprecipitates formed between mouse IgG and rabbit antibodies against mouse IgG. The CAR present in HeLa cell lysates also bound to the affinity-purified immunoglobulins on Immobilon membranes, showing that the association is not limited to the recombinant protein. These results demonstrate that the CAR binds IgG and IgM present in serum, and reveal a direct interaction between the coxsackievirus and adenovirus receptor and the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724543     DOI: 10.1021/bi015571y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.

Authors:  Cecilia Tami; Erica Silberstein; Mohanraj Manangeeswaran; Gordon J Freeman; Sarah E Umetsu; Rosemarie H DeKruyff; Dale T Umetsu; Gerardo G Kaplan
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Functional effects of coxsackievirus and adenovirus receptor glycosylation on homophilic adhesion and adenoviral infection.

Authors:  Katherine J D Ashbourne Excoffon; Nicholas Gansemer; Geri Traver; Joseph Zabner
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.

Authors:  Ian G Goodfellow; David J Evans; Anna M Blom; Dave Kerrigan; J Scott Miners; B Paul Morgan; O Brad Spiller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.

Authors:  A Dörner; H-P Grunert; V Lindig; K Chandrasekharan; H Fechner; K U Knowlton; A Isik; M Pauschinger; H Zeichhardt; H-P Schultheiss
Journal:  J Mol Med (Berl)       Date:  2006-08-05       Impact factor: 4.599

5.  Autoimmunity in Coxsackievirus B3 induced myocarditis: role of estrogen in suppressing autoimmunity.

Authors: 
Journal:  Future Virol       Date:  2010-05-01       Impact factor: 1.831

6.  Layered peptide arrays: high-throughput antibody screening of clinical samples.

Authors:  Gallya Gannot; Michael A Tangrea; John W Gillespie; Heidi S Erickson; Benjamin S Wallis; Rose Anne Leakan; Vladimir Knezevic; Dan P Hartmann; Rodrigo F Chuaqui; Michael R Emmert-Buck
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.